查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829867

2025年全球植入式输液帮浦市场报告

Implantable Infusion Pumps Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，植入式输液帮浦市场稳定成长，市场规模从2024年的195.9亿美元成长至2025年的203.2亿美元，复合年增长率为3.7%。预测期内的成长归因于慢性病管理、人口老化、疼痛管理以及监管核准。

植入式输液帮浦市场规模预计在未来几年强劲成长，2029年将达到264.9亿美元，年复合成长率(CAGR)为6.9%。预测期内的成长归因于个人化医疗、远端患者监护、药物开发和慢性病管理。预测期内的主要趋势包括微创植入、远端监测和程式设计、鞘内疼痛管理以及多学科协作。

植入式输液帮浦是一种先进的药物输送系统，旨在透过手术植入患者体内。这些装置负责将药物以可控且精确的方式直接输送到血液中。

植入式输液帮浦市场细分为病患自控镇痛 (PCA) 帮浦、肠内帮浦、胰岛素帮浦、弹性帮浦、注射式帮浦等。例如，胰岛素帮浦是在手术过程中植入皮下的小型装置，用于为糖尿病患者持续提供胰岛素。这些植入式输液帮浦应用于各个医疗领域，包括肿瘤科、小儿科/新生儿科、胃肠病学、血液科和糖尿病科。它们通常用于医院、门诊手术中心和专科诊所等医疗机构，为患者提供有效且精准的药物输送。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供植入式输液泵的市场统计数据，包括全球市场规模、各地区市场份额、各竞争对手的市场份额、详细的植入式输液泵细分市场、市场趋势和商机，以及您在植入式输液泵行业取得成功所需的数据。本植入式输液帮浦市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年的预测成长率为6.9%，较我们先前对该市场的预测略有下降0.2%。下降的主要原因是美国与其他国家之间关税的影响。这种影响可能会直接波及美国，导致来自义大利和荷兰等主要地区的蠕动微泵和可再填充药室的供应链中断，从而可能减少痉挛管理方案，并增加鞘内给药的成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也可能更为广泛。

慢性疼痛、癌症和糖尿病等慢性疾病的日益普及预计将推动对植入式输液帮浦的需求。输液帮浦通常用于注射治疗这些疾病的药物。由于老化和生活方式的改变，全球慢性疾病和残疾的逐渐增加凸显了对此类医疗设备的需求。例如，根据美国癌症协会在 2022 年 1 月发布的报告，预计 2022 年美国将新增 190 万例癌症病例，并有 609,360 人死亡。此外，估计将有 10,470 名儿童和 5,480 名青少年罹患癌症。慢性病的增加预计将大大促进植入式输液帮浦市场的成长。

预计老龄人口的不断增长将进一步推动植入式输液泵市场的成长。植入式输液帮浦广泛用于管理慢性疾病，这对于日益增长的老龄化人口至关重要，因为他们可以从这些设备中受益。根据世界卫生组织（WHO）2022年10月发布的报告，预计到2030年，全球六分之一的人口将年龄在60岁或以上，而2020年至2050年间，80岁或以上人口的数量将增加4.26亿。预计到2050年，全球60岁或以上人口将达到21亿，老龄化社会可能会继续推动对植入式输液帮浦的需求。

植入式输液帮浦产业的公司越来越重视智慧输液帮浦的开发。无线技术在医疗监测设备的应用日益广泛，提升了设备的可用性、连接性和数据分析能力。无线技术的整合使得数据可以透过蓝牙或行动电话连接从设备无缝传输到智慧型手机和其他无线设备。这有助于数据处理、显示和后续分析，从而检查个人的健康状况。此外，软体平台也在不断创新，以实现患者监测并减少过程中出现人为错误的可能性。

为了扩大客户群、推动销售并增加收益，植入式输液帮浦市场的主要企业正专注于开发新产品，例如胰岛素帮浦。胰岛素帮浦是一种旨在帮助糖尿病患者管理血糖值的医疗设备。值得注意的是，2023 年 4 月，总部位于爱尔兰的医疗设备公司Medtronic宣布其 MiniMed 780G 系统获得 FDA核准，该系统采用进餐检测技术。该产品的与众不同之处在于，它提供市面上所有自动胰岛素帮浦中最低的血糖目标值（低至 100 mg/dL），旨在密切反映非糖尿病患者的平均血糖浓度。该系统以目标治疗为基础运行，自动调整和自动校正基础胰岛素以达到特定目标。此外，它是唯一一款配备输液器的泵，可舒适地佩戴长达七天。这种延长的配戴时间得益于先进的材料，这些材料可最大限度地减少胰岛素储存溶液的损失，保持稳定的胰岛素流量和稳定性，并降低输液器堵塞的可能性。

2022年3月，总部位于巴黎的医疗设备和医疗保健解决方案製造商Vygon SAS收购了Macatt Medica Peruana SAC，收购金额未揭露。此次收购旨在增强Vygon的产品系列，扩大其市场覆盖范围，整合创新技术，并提升其竞争地位。总部位于秘鲁的Macatt Medica Peruana SAC专注于先进医疗设备的开发和製造，特别专注于用于直接给药的输液系统。

企业发展式输液帮浦市场的主要企业包括美敦力公司 (Medtronic PLC)、波士顿科学公司 (Boston Scientific Corporation)、Nevro Corp、LivaNova PLC、百特国际公司 (Baxter International Inc.)、B. Braun Melsungen AG、Fresenius Kabi AG、史密斯集团 (Smiths Group) 旗下的医疗保健公司 (Johnrumson Johnson)、Greatbatch Medical、NeuroPace Inc.、Primetech Corporation、Flowonix Medical Inc.、F. Hoffmann-La Roche Ltd.、深圳迈瑞生物医疗电子股份有限公司 (Shenzhen Mindray Bio-Medical Electronics Co.Ltd.)、Micrel Medical、Insulet Corporation、ICU Medical Inc.、Becton Dick医生 Medical. (Abbott Laboratories)、Hospira、史赛克公司 (Stryker Corporation)、Zimmer Biomet Holdings Inc.、泰利福公司 (Teleflex Incorporated)、CR Bard Inc.、AngioDynamics Inc.、Merit Medical Systems Inc.、NIPRO Medical Corporation、IRadimed Corporation、Zyno Medical、Tricumed Inc.

2024年，植入式输液帮浦市场最大的地区是北美。亚太地区是植入式输液帮浦市场的第二大地区。植入式输液帮浦市场报告涵盖以下地区：亚太地区、西欧、东欧、北美、南美、中东和非洲。

植入式输液帮浦市场报告涵盖的国家包括澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙和加拿大

植入式输液帮浦市场涵盖患者自控镇痛 (PCA) 帮浦、肠内帮浦、胰岛素帮浦、弹性帮浦和注射式帮浦等设备的销售。该市场中的商品价值为出厂价，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球植入式输液帮浦：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球植入式输液帮浦市场：成长率分析
  • 全球植入式输液帮浦市场表现：规模与成长，2019-2024
  • 全球植入式输液帮浦市场预测：规模与成长，2024-2029年，2034年
  • 全球植入式输液帮浦：总目标市场（TAM）

第六章 市场细分

  • 全球植入式输液帮浦市场类型、效能及预测（2019-2024、2024-2029、2034）
  • 病人自控镇痛（PCA）泵
  • 肠内泵
  • 胰岛素帮浦
  • 弹性体泵
  • 注射式帮浦
  • 其他类型
  • 全球植入式输液帮浦市场：应用、效能及预测，2019-2024年、2024-2029年、2034年
  • 肿瘤学
  • 小儿科或新生儿科
  • 胃肠病学
  • 血液学
  • 糖尿病
  • 其他用途
  • 全球植入式输液帮浦市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 全球植入式输液帮浦市场：病人自控镇痛 (PCA) 帮浦细分（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 氢可酮PCA泵
  • FentanylPCA泵
  • 其他阿片类药物 PCA 泵
  • 全球植入式输液帮浦市场：按肠内帮浦类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 管饲帮浦
  • 注射器式肠内泵
  • 定期或间歇供料泵
  • 全球植入式输液帮浦市场：按胰岛素帮浦类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 胰岛素输注泵
  • 胰岛素贴片帮浦
  • 智慧胰岛素泵
  • 全球植入式输液帮浦市场：依弹性体帮浦类型、性能与预测细分，2019-2024 年、2024-2029 年、2034 年
  • 一次性弹性体泵
  • 可重复使用的弹性体泵
  • 全球植入式输液帮浦市场：细分注射式帮浦（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 小容量注射式帮浦
  • 大容量注射式帮浦
  • 全球植入式输液帮浦市场：按类型（其他）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 化疗输液泵
  • 抗生素输液泵
  • 疼痛管理泵

第七章 区域和国家分析

  • 全球植入式输液帮浦市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球植入式输液帮浦市场：依国家、地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 植入式输液帮浦市场：竞争格局
  • 植入式输液帮浦市场：公司简介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Nevro Corp Overview, Products and Services, Strategy and Financial Analysis
    • LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Smiths Medical, a Smiths Group company
  • Terumo Corporation
  • Johnson & Johnson
  • Greatbatch Medical
  • NeuroPace Inc.
  • Primetech Corporation
  • Flowonix Medical Inc.
  • F. Hoffmann-La Roche Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Micrel Medical
  • Insulet Corporation
  • ICU Medical Inc.
  • Becton Dickinson and Company（BD）

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年植入式输液帮浦市场：提供新机会的国家
  • 2029年植入式输液帮浦市场：细分市场带来新机会
  • 2029年植入式输液帮浦市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r32598u

Implantable infusion pumps are advanced drug delivery systems designed to be surgically implanted within a patient's body. These devices are responsible for controlled and precise administration of medication directly into the bloodstream.

The implantable infusion pumps market is categorized into several types, including patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, and other variations. For instance, insulin pumps are small devices implanted under the skin during surgical procedures to continuously deliver insulin for patients with diabetes. These implantable infusion pumps find applications across various medical fields, including oncology, pediatrics/neonatology, gastroenterology, hematology, diabetes, and more. They are commonly used in healthcare settings such as hospitals, ambulatory surgical centers, and specialty clinics to provide effective and precise drug delivery to patients.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The implantable infusion pumps market research report is one of a series of new reports from The Business Research Company that provides implantable infusion pumps market statistics, including implantable infusion pumps industry global market size, regional shares, competitors with a implantable infusion pumps market share, detailed implantable infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the implantable infusion pumps industry. This implantable infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable infusion pumps market size has grown steadily in recent years. It will grow from $19.59 billion in 2024 to $20.32 billion in 2025 at a compound annual growth rate (CAGR) of 3.7%. The growth in the historic period can be attributed to chronic disease management, aging population, pain management, regulatory approvals.

The implantable infusion pumps market size is expected to see strong growth in the next few years. It will grow to $26.49 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to personalized medicine, remote patient monitoring, drug development, chronic disease management. Major trends in the forecast period include minimally invasive implantation, remote monitoring and programming, intrathecal pain management, interdisciplinary collaboration.

The forecast of 6.9% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for peristaltic micro-pumps and refillable medication chambers, sourced from key regions such as Italy and the Netherlands, which could lead to reduced options for spasticity management and increased costs for intrathecal drug delivery.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The escalating prevalence of chronic conditions such as chronic pain, cancer, and diabetes is anticipated to be a driving force behind the demand for implantable infusion pumps. These pumps are commonly utilized to administer pharmaceutical drugs for treating these ailments. The gradual increase in chronic illnesses and disorders worldwide, primarily attributed to an aging population and shifts in lifestyle, underscores the need for such medical devices. For example, a report published by the American Cancer Society in January 2022 highlighted an anticipated 1.9 million new cancer cases in the US in 2022, with 609,360 projected deaths. An estimated 10,470 pediatric cancer cases and 5,480 teenage cancer diagnoses are also expected. This rise in chronic diseases is projected to significantly contribute to the growth of the implantable infusion pumps market.

The expanding aging population is predicted to further fuel the growth of the implantable infusion pumps market. Implantable infusion pumps are extensively used in the management of chronic conditions, making them crucial for a growing aging demographic that can benefit from these devices. A report by the World Health Organization (WHO) in October 2022 revealed that by 2030, one in six individuals globally will be 60 or older, while the number of individuals aged 80 or older is estimated to increase by 426 million between 2020 and 2050. With projections indicating 2.1 billion people worldwide aged 60 or older by 2050, the rising aging population will continue to drive the demand for implantable infusion pumps.

Market players in the implantable infusion pump industry are increasingly prioritizing the development of smart infusion pumps. The utilization of wireless technology in healthcare monitoring devices is on the rise, providing improved ease of use, connectivity, and data analysis. Integrating wireless technology allows seamless data transfer from the device to a smartphone or another wireless device using Bluetooth or cellular connections. This facilitates data processing, display, and subsequent analysis for studying the individual's health condition. Moreover, software platforms are being innovated to enable patient monitoring and reduce the occurrence of human error in the process.

Leading companies in the implantable infusion pump market are focusing on the development of new products, such as insulin pumps, to address a broader customer base, boost sales, and increase revenue. Insulin pumps are medical devices designed to assist individuals with diabetes in managing their blood sugar levels. Notably, in April 2023, Medtronic, an Ireland-based medical device company, announced the FDA approval for the MiniMed 780G System featuring meal detection technology. This product distinguishes itself by setting the lowest glucose target (as low as 100 mg/dL) among all automated insulin pumps available in the market, aiming to closely mirror the average glucose levels of individuals without diabetes. The system operates on a treat-to-target basis, automatically making basal insulin adjustments and autocorrections to attain a specific target. Additionally, it stands out as the only pump featuring an infusion set that can be worn comfortably for an extended period of up to 7 days. This extended wear time is facilitated by advanced materials that minimize insulin preservative loss, maintaining consistent insulin flow and stability while reducing the likelihood of infusion set occlusion.

In March 2022, Vygon SAS, a Paris-based manufacturer of medical devices and healthcare solutions, acquired Macatt Medica Peruana SAC for an undisclosed amount. The acquisition aims to bolster Vygon's product portfolio, expand its market reach, integrate innovative technologies, and enhance its competitive position. Macatt Medica Peruana SAC, a Peru-based company, specializes in the development and production of advanced medical devices, with a particular focus on infusion systems for direct medication delivery.

Major companies operating in the implantable infusion pumps market include Medtronic PLC, Boston Scientific Corporation, Nevro Corp, LivaNova PLC, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical a Smiths Group company, Terumo Corporation, Johnson & Johnson, Greatbatch Medical, NeuroPace Inc., Primetech Corporation, Flowonix Medical Inc., F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Micrel Medical, Insulet Corporation, ICU Medical Inc., Becton Dickinson and Company (BD), Roche Diagnostics International AG, Abbott Laboratories, Hospira, Stryker Corporation, Zimmer Biomet Holdings Inc., Teleflex Incorporated, C. R. Bard Inc., AngioDynamics Inc., Merit Medical Systems Inc., NIPRO Medical Corporation, IRadimed Corporation, Zyno Medical, Tricumed Medizintechnik GmbH, Q Core Medical Ltd., Ivenix Inc., Tandem Diabetes Care Inc.

North America was the largest region in the implantable infusion pumps market in 2024. Asia-Pacific was the second-largest region in the implantable infusion pumps market. The regions covered in the implantable infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the implantable infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The implantable infusion pumps market consists of sales of instruments such as patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Infusion Pumps Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable infusion pumps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable infusion pumps market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Patient-Controlled Analgesia (PCA) Pumps; Enteral Pumps; Insulin Pumps; Elastomeric Pumps; Syringe Pumps; Other Types
  • 2) By Applications: Oncology; Pediatrics Or Neonatology; Gastroenterology; Hematology; Diabetes; Other Applications
  • 3) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
  • Subsegments:
  • 1) By Patient-Controlled Analgesia (PCA) Pumps: Morphine PCA Pumps; Fentanyl PCA Pumps; Other Opioid PCA Pumps
  • 2) By Enteral Pumps: Tube Feeding Pumps; Syringe-based Enteral Pumps; Continuous Or Intermittent Feeding Pumps
  • 3) By Insulin Pumps: Insulin Delivery Pumps; Insulin Patch Pumps; Smart Insulin Pumps
  • 4) By Elastomeric Pumps: Disposable Elastomeric Pumps; Reusable Elastomeric Pumps
  • 5) By Syringe Pumps: Small Volume Syringe Pumps; Large Volume Syringe Pumps
  • 6) By Other Types: Chemotherapy Infusion Pumps; Antibiotic Infusion Pumps; Pain Management Pumps
  • Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Nevro Corp; LivaNova PLC; Baxter International Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; Smiths Medical a Smiths Group company; Terumo Corporation; Johnson & Johnson; Greatbatch Medical; NeuroPace Inc.; Primetech Corporation; Flowonix Medical Inc.; F. Hoffmann-La Roche Ltd; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Micrel Medical; Insulet Corporation; ICU Medical Inc.; Becton Dickinson and Company (BD); Roche Diagnostics International AG; Abbott Laboratories; Hospira; Stryker Corporation; Zimmer Biomet Holdings Inc.; Teleflex Incorporated; C. R. Bard Inc.; AngioDynamics Inc.; Merit Medical Systems Inc.; NIPRO Medical Corporation; IRadimed Corporation; Zyno Medical; Tricumed Medizintechnik GmbH; Q Core Medical Ltd.; Ivenix Inc.; Tandem Diabetes Care Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Infusion Pumps Market Characteristics

3. Implantable Infusion Pumps Market Trends And Strategies

4. Implantable Infusion Pumps Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Implantable Infusion Pumps Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Infusion Pumps PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Infusion Pumps Market Growth Rate Analysis
  • 5.4. Global Implantable Infusion Pumps Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Infusion Pumps Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Infusion Pumps Total Addressable Market (TAM)

6. Implantable Infusion Pumps Market Segmentation

  • 6.1. Global Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patient-Controlled Analgesia (PCA) Pumps
  • Enteral Pumps
  • Insulin Pumps
  • Elastomeric Pumps
  • Syringe Pumps
  • Other Types
  • 6.2. Global Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Pediatrics Or Neonatology
  • Gastroenterology
  • Hematology
  • Diabetes
  • Other Applications
  • 6.3. Global Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • 6.4. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Patient-Controlled Analgesia (PCA) Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Morphine PCA Pumps
  • Fentanyl PCA Pumps
  • Other Opioid PCA Pumps
  • 6.5. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Enteral Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tube Feeding Pumps
  • Syringe-based Enteral Pumps
  • Continuous or Intermittent Feeding Pumps
  • 6.6. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Insulin Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Delivery Pumps
  • Insulin Patch Pumps
  • Smart Insulin Pumps
  • 6.7. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Elastomeric Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Elastomeric Pumps
  • Reusable Elastomeric Pumps
  • 6.8. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Syringe Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Small Volume Syringe Pumps
  • Large Volume Syringe Pumps
  • 6.9. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chemotherapy Infusion Pumps
  • Antibiotic Infusion Pumps
  • Pain Management Pumps

7. Implantable Infusion Pumps Market Regional And Country Analysis

  • 7.1. Global Implantable Infusion Pumps Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Infusion Pumps Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Infusion Pumps Market

  • 8.1. Asia-Pacific Implantable Infusion Pumps Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Infusion Pumps Market

  • 9.1. China Implantable Infusion Pumps Market Overview
  • 9.2. China Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Infusion Pumps Market

  • 10.1. India Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Infusion Pumps Market

  • 11.1. Japan Implantable Infusion Pumps Market Overview
  • 11.2. Japan Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Infusion Pumps Market

  • 12.1. Australia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Infusion Pumps Market

  • 13.1. Indonesia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Infusion Pumps Market

  • 14.1. South Korea Implantable Infusion Pumps Market Overview
  • 14.2. South Korea Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Infusion Pumps Market

  • 15.1. Western Europe Implantable Infusion Pumps Market Overview
  • 15.2. Western Europe Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Infusion Pumps Market

  • 16.1. UK Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Infusion Pumps Market

  • 17.1. Germany Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Infusion Pumps Market

  • 18.1. France Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Infusion Pumps Market

  • 19.1. Italy Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Infusion Pumps Market

  • 20.1. Spain Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Infusion Pumps Market

  • 21.1. Eastern Europe Implantable Infusion Pumps Market Overview
  • 21.2. Eastern Europe Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Infusion Pumps Market

  • 22.1. Russia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Infusion Pumps Market

  • 23.1. North America Implantable Infusion Pumps Market Overview
  • 23.2. North America Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Infusion Pumps Market

  • 24.1. USA Implantable Infusion Pumps Market Overview
  • 24.2. USA Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Infusion Pumps Market

  • 25.1. Canada Implantable Infusion Pumps Market Overview
  • 25.2. Canada Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Infusion Pumps Market

  • 26.1. South America Implantable Infusion Pumps Market Overview
  • 26.2. South America Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Infusion Pumps Market

  • 27.1. Brazil Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Infusion Pumps Market

  • 28.1. Middle East Implantable Infusion Pumps Market Overview
  • 28.2. Middle East Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Infusion Pumps Market

  • 29.1. Africa Implantable Infusion Pumps Market Overview
  • 29.2. Africa Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Infusion Pumps Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Infusion Pumps Market Competitive Landscape
  • 30.2. Implantable Infusion Pumps Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Nevro Corp Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Infusion Pumps Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Fresenius Kabi AG
  • 31.3. Smiths Medical, a Smiths Group company
  • 31.4. Terumo Corporation
  • 31.5. Johnson & Johnson
  • 31.6. Greatbatch Medical
  • 31.7. NeuroPace Inc.
  • 31.8. Primetech Corporation
  • 31.9. Flowonix Medical Inc.
  • 31.10. F. Hoffmann-La Roche Ltd
  • 31.11. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • 31.12. Micrel Medical
  • 31.13. Insulet Corporation
  • 31.14. ICU Medical Inc.
  • 31.15. Becton Dickinson and Company (BD)

32. Global Implantable Infusion Pumps Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Infusion Pumps Market

34. Recent Developments In The Implantable Infusion Pumps Market

35. Implantable Infusion Pumps Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Infusion Pumps Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Infusion Pumps Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Infusion Pumps Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer